Analysis and Comparison of Two Artificial Intelligence Diabetic Retinopathy Screening Algorithms in a Pilot Study: IDx-DR and Retinalyze
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: The prevalence of diabetic retinopathy (DR) is expected to increase. This will put an increasing strain on health care resources. Recently, artificial intelligence-based, autonomous DR screening systems have been developed. A direct comparison between different systems is often difficult and only two such comparisons have been published so far. As different screening solutions are now available commercially, with more in the pipeline, choosing a system is not a simple matter. Based on the images gathered in a local DR screening program we performed a retrospective comparison of IDx-DR and Retinalyze. Methods: We chose a non-representative sample of all referable DR positive screening subjects (n = 60) and a random selection of DR negative patient images (n = 110). Only subjects with four good quality, 45-degree field of view images, a macula-centered and disc-centered image from both eyes were chosen for comparison. The images were captured by a Topcon NW-400 fundus camera, without mydriasis. The images were previously graded by a single ophthalmologist. For the purpose of this comparison, we assumed two screening strategies for Retinalyze—where either one or two out of the four images needed to be marked positive by the system for an overall positive result at the patient level. Results: Percentage agreement with a single reader in DR positive and DR negative cases respectively was: 93.3%, 95.5% for IDx-DR; 89.7% and 71.8% for Retinalyze strategy 1; 74.1% and 93.6% for Retinalyze under strategy 2. Conclusions: Both systems were able to analyse the vast majority of images. Both systems were easy to set up and use. There were several limitations to the current pilot study, concerning sample choice and the reference grading that need to be addressed before attempting a more robust future study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ting, D. S. W., Cheung, C. Y.-L., Lim, G., Tan, G. S. W., Quang, N. D., Gan, A., Hamzah, H., Garcia-Franco, R., San Yeo, I. Y., Lee, S. Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.18152 · Cited by 2,402
Can we open the black box of AI?
Castelvecchi, D. (2016) · Nature · doi:10.1038/538020a · Cited by 1,773
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638
Abràmoff, M. D., Lou, Y., Erginay, A., Clarida, W., Amelon, R., Folk, J. C., & Niemeijer, M. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.16-19964 · Cited by 1,101
Artificial intelligence for diabetic retinopathy screening: a review
Grzybowski, A., Brona, P., Lim, G., Ruamviboonsuk, P., Tan, G. S. W., Abramoff, M., & Ting, D. S. W. (2020) · Eye · doi:10.1038/s41433-019-0566-0 · Cited by 376 · cited 1×
“A number of artificial intelligence solutions for use in DR screening programs, some authorized for autonomous use, are currently available with more in the pipeline [6].”
BackgroundRuamviboonsuk, P., Krause, J., Chotcomwongse, P., Sayres, R., Raman, R., Widner, K., Campana, B. J. L., Phene, S., Hemarat, K., Tadarati, M., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0099-8 · Cited by 233
Bhaskaranand, M., Ramachandra, C., Bhat, S., Cuadros, J., Nittala, M. G., Sadda, S. R., & Solanki, K. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0164 · Cited by 211 · cited 1×
“As a result, some of the more robust trials evaluating a given AI DR system opted for the use of 7-field images, stereoscopic images and even OCT scans to aid human graders [5,9].”
Lee, A. Y., Yanagihara, R. T., Lee, C. S., Blazes, M., Jung, H. C., Chee, Y. E., Gencarella, M. D., Gee, H., Maa, A. Y., Cockerham, G. C., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1877 · Cited by 194
Cited by
Yelne, S., Chaudhary, M., Dod, K., Sayyad, A., & Sharma, R. (2023) · Cureus · doi:10.7759/cureus.49252 · Cited by 190
KHAN, Z., GAIDHANE, A. M., SINGH, M., GANESAN, S., KAUR, M., SHARMA, G. C., RANI, P., SHARMA, R., THAPLIYAL, S., KUSHWAHA, M., et al. (2025) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2025.02.022 · Cited by 49
Grzybowski, A., Rao, D. P., Brona, P., Negiloni, K., Krzywicki, T., & Savoy, F. M. (2023) · Ophthalmic Research · doi:10.1159/000534098 · Cited by 33
Self-citationMoannaei, M., Jadidian, F., Doustmohammadi, T., Kiapasha, A. M., Bayani, R., Rahmani, M., Jahanbazy, M. R., Sohrabivafa, F., Asadi Anar, M., Magsudy, A., et al. (2025) · BioMedical Engineering OnLine · doi:10.1186/s12938-025-01336-1 · Cited by 18
Evaluation of ChatGPT-4 in detecting referable diabetic retinopathy using single fundus images
Aftab, O., Khan, H., VanderBeek, B. L., Scoles, D., Kim, B. J., & Tsui, J. C. (2025) · AJO International · doi:10.1016/j.ajoint.2025.100111 · Cited by 10
Metadata
- Authors
- Grzybowski, A., & Brona, P.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-05-27
- Volume
- 10
- Issue
- 11
- Pages
- 2352
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3164006967
- Cited by
- 66
- References
- 8
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.